Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Apoptotic Pathway
50%
Cancer Cell Lines
50%
Cellular Proteins
50%
Changes in Gene Expression
100%
Colon Cancer Cell Line HT29
50%
Complementary DNA Microarray
50%
Cytotoxicity Assay
50%
DNA Microarray chip
50%
Functional Analysis
100%
G207
50%
Gene Expression Pattern
100%
Gene Ontology
50%
Gene Signature
50%
Hepatoma Cells
50%
Herpes Simplex Virus
50%
HT-29
50%
Human Genome
50%
Interaction Pathway
50%
Microarray Analysis
50%
Molecular Assay
50%
Molecular Network
100%
Multiplicity of Infection
50%
Network Interaction
50%
Network Pathway
100%
Novel Treatments
50%
Nucleotide Pool
50%
Oncolytic Therapy
50%
Oncolytic Viral Therapy
50%
Overcoming Resistance
50%
Path Analysis
100%
Patient Selection
50%
Replication-competent
50%
Resistance Development
100%
Resistant Cell Lines
50%
Resistant Cells
100%
Surface Proteins
50%
Therapy-resistant
100%
Tumor
50%
Tumor Signature
100%
Tumorigenicity
50%
Viral Attachment
50%
Viral Entry
50%
Viral Gene Therapy
100%
Viral Infection
50%
Viral Replication
50%
Viral Therapy
50%
Virus
50%
Medicine and Dentistry
Cancer Cell Line
33%
Carcinogenicity
33%
Cell Line
100%
Cell Protein
33%
Cell Surface Protein
33%
Colon Cancer Cell Line
33%
Complementary DNA
33%
Cytotoxicity Assay
33%
DNA Microarray
33%
G 207
33%
Gene Expression
100%
Gene Expression Profiling
33%
Hepatoma Cell
33%
Herpes Simplex Virus
33%
Human Genome
33%
In Vitro
33%
Infection
33%
Interaction Network
33%
Microarray Analysis
33%
Neoplasm
100%
Oncolytic Virotherapy
33%
Resistant Cell Line
33%
Viral Gene Therapy
100%
Virotherapy
33%
Virus Attachment
33%
Virus Entry
33%
Virus Infection
33%
Virus Replication
33%
Immunology and Microbiology
Cancer Cell Line
33%
Cell Line
100%
Cell Surface
33%
Colon Cancer Cell Line
33%
Cytotoxicity
33%
DNA Microarray
33%
G 207
33%
Gene Expression
100%
Gene Expression Assay
33%
Gene Ontology
33%
Hepatoma Cell
33%
Herpes Simplex Virus
33%
Human Genome
33%
Multiplicity of Infection
33%
Resistant Cell Line
33%
Viral Disease
33%
Viral Entry
33%
Viral Replication
33%
Virotherapy
66%
Virus Attachment
33%
Virus Gene
100%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenicity
50%
Cell Protein
50%
Cell Surface Protein
50%
Colon Carcinoma
50%
Complementary DNA
50%
Cytotoxicity Assay
50%
G 207
50%
Herpes Simplex Virus
50%
Infection
50%
Liver Cell Carcinoma
50%
Malignant Neoplasm
50%
Neoplasm
100%
Virotherapy
100%
Virus Infection
50%